Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 2/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.47 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.47 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23323100 | 1.00 | HTR2C (0.52) | HTR2CCHRM2CHRM5CHRM3CHRM4 | |
| SCHEMBL31444509 | 1.00 | HTR2C (0.52) | HTR2CCHRM2CHRM5CHRM3CHRM4 | |
| SCHEMBL29747537 | 1.00 | HTR2C (0.52) | HTR2CCHRM2CHRM5CHRM3CHRM4 | |
| SCHEMBL3331668 | 1.00 | HTR2C (0.52) | HTR2CCHRM2CHRM5CHRM3CHRM4 | |
| Hydrochloric Acid SCHEMBL31648861 | 0.98 | HTR2C (0.53) | HTR2CCHRM2CHRM5CHRM3CHRM4 | |
| SCHEMBL13451469 | 0.94 | HTR2C (0.50) | HTR2CCHRM2CHRM5CHRM3CHRM4 | |
| SCHEMBL17304029 | 0.94 | HTR2C (0.50) | HTR2CCHRM2CHRM5CHRM3CHRM4 | |
| SCHEMBL2706383 | 0.94 | HTR2C (0.50) | HTR2CCHRM2CHRM5CHRM3CHRM4 | |
| SCHEMBL7672097 | 0.93 | HTR2C (0.49) | HTR2CCHRM2CHRM5CHRM3CHRM4 | |
| Hydrochloric Acid SCHEMBL15284187 | 0.93 | HTR2C (0.51) | HTR2CCHRM2CHRM5CHRM3CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |